Curriculum

Managing GERD in 2024: An Update for Primary Care Clinicians

CME Information

1.00 AMA PRA Category 1 Credits™, 1.00 ABIM MOC or 1.02 AANP, 0.77 AANP Pharm

Release Date: 3/29/2024

Available for credit until 3/29/2025

Learning Objectives

  • Describe the burden of GERD with respect to prevalence, impact on quality of life, and consequences of progression
  • Summarize the benefits and limitations of PPIs in patients with GERD, and incorporate practical tips for optimizing their use into clinical practice
  • Summarize the latest evidence regarding the efficacy and safety of P-CABs in GERD management
  • Incorporate best practice recommendations for educating patients regarding PPIs and de-prescribing these agents when appropriate

Courses

1.00 CME/CE CREDIT

4 Courses

Faculty

Joan W. Chen, MD, MS

Clinical Associate Professor of Medicine and Director of Esophageal Motility, Division of Gastroenterology & Hepatology, Clinical Director of Esophageal Service Line, Department of Internal Medicine University of Michigan, University of Michigan, Ann Arbor, MI

Learn More

Supporters and Partners

Supported by

Phathom Pharmaceuticals, Inc.

Education Partner

VRIS Group, LLC